Last reviewed · How we verify

Terconazole/metronidazole

Curatek Pharmaceuticals, LLC · Phase 3 active Small molecule

Terconazole and metronidazole are antifungal and antibacterial agents that work by inhibiting the synthesis of ergosterol and DNA replication, respectively.

Terconazole and metronidazole are antifungal and antibacterial agents that work by inhibiting the synthesis of ergosterol and DNA replication, respectively. Used for Vaginal candidiasis, Bacterial vaginosis.

At a glance

Generic nameTerconazole/metronidazole
SponsorCuratek Pharmaceuticals, LLC
Drug classazole antifungal and nitroimidazole antibacterial
ModalitySmall molecule
Therapeutic areaGynecology
PhasePhase 3

Mechanism of action

Terconazole is a triazole antifungal that inhibits the enzyme lanosterol 14α-demethylase, preventing the conversion of lanosterol to ergosterol, an essential component of fungal cell membranes. Metronidazole is a nitroimidazole antibacterial that works by entering the cell and causing DNA damage through the formation of free radicals, ultimately leading to cell death.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results